Artificial intelligence in precision medicine: transforming disease subtyping, medical imaging, and pharmacogenomics.

Andrea Rodriguez-Martinez¹, Dilini Kothalawala², Rodrigo M Carrillo-Larco³, Antonios Poulakakis-Daktylidis²

¹Medical Research Council Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, U.K.

²BenevolentAI, London, U.K.

³Hubert Department of Global Health, Rollins School of Public Health, Emory University, GA, U.S.A.

PubMed PMC DOI PDF

Abstract

Precision medicine marks a transformative shift towards a patient-centric treatment approach, aiming to match 'the right patients with the right drugs at the right time'. The exponential growth of data from diverse omics modalities, electronic health records, and medical imaging has created unprecedented opportunities for precision medicine. This explosion of data requires advanced processing and…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.